Getting Oxbryta (Voxelotor) Covered by Aetna CVS Health in Virginia: 2024 Updates, Appeals, and Alternatives
Quick Answer: Oxbryta Coverage Status in Virginia
Important Update: Oxbryta (voxelotor) is no longer FDA-approved in the United States as of 2024. Pfizer withdrew the drug following a confirmatory evidence review. If you're in Virginia with Aetna CVS Health coverage and need sickle cell disease treatment, focus on